Stifel’s 2025 Biotech Summer Summit August 11 – 13, 2025, Newport, Rhode Island Fireside Chat: August 11, 1:00 p.m. ET Trevi ...

In addition to Stifel Nicolaus, Viking Therapeutics also received a Buy from William Blair’s Andy Hsieh in a report issued today. However, yesterday, Citi maintained a Hold rating on Viking ...

In a population not selected for risk, the cumulative incidence of atopic dermatitis at 24 months was 36.1% for those in the daily emollients group versus 43% for those in the control group (relative ...

Reports that the Trevi Fountain will be the next Italian attraction to start charging visitors a fee have sparked controversy – but is it really going to happen?

Rome switched off the lights of its iconic Trevi Fountain for one hour in a symbolic and urgent appeal for a ceasefire in ...

Rome dimmed the lights of the iconic Trevi Fountain for one hour Friday night in a symbolic call for a ceasefire in the Gaza Strip, following a city council resolution last month that was titled, ...

Rome dimmed the lights of the iconic Trevi Fountain for one hour Friday night in a symbolic call for a ceasefire in the Gaza ...

Detailed price information for Eupraxia Pharmaceuticals Inc (EPRX-Q) from The Globe and Mail including charting and trades.

Trevi Therapeutics, Inc. (TRVI) closed the last trading session at $6.41, gaining 3.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set ...

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in ...

Trevi Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates Provided by PR Newswire May 8, 2025, 1:05:00 PM ...

Trevi Therapeutics, Inc. (NASDAQ:TRVI – Get Free Report) has been given an average rating of “Buy” by the ten research firms that are covering the firm, MarketBeat.com reports. Seven ...